Allogene Therapeutics Inc (ALLO)
2.93
+0.02
(+0.51%)
USD |
NASDAQ |
May 02, 15:37
Allogene Therapeutics Cash and Short Term Investments (Quarterly): 448.70M for Dec. 31, 2023
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 448.70M |
| September 30, 2023 | 465.50M |
| June 30, 2023 | 491.96M |
| March 31, 2023 | 471.22M |
| December 31, 2022 | 517.32M |
| September 30, 2022 | 552.23M |
| June 30, 2022 | 490.49M |
| March 31, 2022 | 449.05M |
| December 31, 2021 | 457.30M |
| September 30, 2021 | 483.48M |
| June 30, 2021 | 587.71M |
| March 31, 2021 | 699.58M |
| Date | Value |
|---|---|
| December 31, 2020 | 827.91M |
| September 30, 2020 | 841.02M |
| June 30, 2020 | 899.65M |
| March 31, 2020 | 492.92M |
| December 31, 2019 | 530.53M |
| September 30, 2019 | 501.24M |
| June 30, 2019 | 502.42M |
| March 31, 2019 | 466.14M |
| December 31, 2018 | 459.38M |
| September 30, 2018 | 244.22M |
| June 30, 2018 | 293.93M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
448.70M
Minimum
Dec 2023
899.65M
Maximum
Jun 2020
563.70M
Average
501.24M
Median
Sep 2019
Cash and Short Term Investments (Quarterly) Benchmarks
| Agenus Inc | 76.11M |
| ANI Pharmaceuticals Inc | 221.12M |
| Vaxart Inc | 39.71M |
| aTyr Pharma Inc | 98.17M |
| PAVmed Inc | 19.64M |